TokenPost·
Mereo BioPharma Posts $800,000 in Q3 Revenue and $0.01 Loss Per Share
The quarter ended Sept. 30, 2026, and the reported loss was basic and diluted.
More news
- TokenPostSonoco Names Ernest D. Haynes III CEO as Coker Plans Retirement
- TokenPostU.S. Government Plans Briefing on Matter Involving Nvidia CEO
- TokenPostIGC Pharma Reports $0.32 Million in Third-Quarter Revenue
- TokenPostGoogle Makes Pathways on Google Kubernetes Engine Generally Available
- TokenPostKALA BIO, Inc. Narrows Preliminary Q3 Net Loss to About $0.8 Million
- TokenPostGlobal Ship Lease Posts $2.75 GAAP EPS in Third Quarter